Stock screenerAll disclosures →
EDGAR →
MRK
Conviction 80HealthcareScan · Tue, Sep 8, 2026MRK$148.48-1.23%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
2
4
6
Vol MA14 11.85M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price148.48
Change-1.23%
Gap-1.31%
Rel volume0.53×
Avg volume10.86M
Avg $ vol1.6B
SMA 20145.91
SMA 50134.99
SMA 200118.67
Price vs 50+10.00%
Price vs 200+25.13%
MA stackbullish
50/200 cross—
Supertrendup · 139.81
RSI (14)59
MACD hist-0.51
MACD crossbear · 1d
Stoch %K / %D30 / 60
ADX (14)41
+DI / −DI31 / 19
RSI divergence—
MACD divergence—
ATR %+2.66%
ADR %2.49%
52w high156.45
52w low77.60
From 52w high-5.09%
Above 52w low+91.34%
New 52w highNo
SqueezeOff
Bollinger width21.66%
%B0.58
Donchian pos69.87%
Donchian high156.92
Donchian low128.91
AVWAP (52w high)150.79
vs AVWAP high-1.53%
AVWAP (52w low)112.03
vs AVWAP low+32.54%
OBV trendFlat
Chaikin MF (20)0.19
Today vs 20d0.53×
Avg vol (14d)11.85M
Avg vol (20d)10.86M
Avg $ vol (20d)1.6B
Market cap366.33B
RS 3m (vs SPY)+20.03%
RS 6m (vs SPY)+15.28%
RS line new highNo
Trend template8/8
Technical rank83.9
1 week+0.49%
1 month+15.48%
3 months+24.23%
6 months+26.79%
1 year+75.28%
YTD+39.48%
P/E20.07
P/B8.74
P/S5.63
P/FCF29.64
EPS7.28
Div yield2.23%
ROE43.53%
ROA14.06%
Debt/Eq1.27
Current1.32
EV/EBITDA—
Gross margin—
Net margin28.08%
Rev growth1.31%
EPS growth6.64%
Price target157.91
Target upside6.35%
Analyst ratingBuy
Institutional90.94%
Ent. value412.86B
Revenue16.61B
Net income-1.33B
Gross profit—
Free cash flow12.36B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out2.47B
Employees75K
ListedWed, Apr 20, 1949
Free float2.44B
Float %98.2%
Short interest24.51M
Days to cover2.8d
Short volume64.0%
Squeeze score32 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.13 vs −$0.26
Last surprise+50.0% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank83.9 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance154.86
Support125.16
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- The Hashgraph Group and Merck with support from PwC Germany develop solution for cocoa traceability and digital product passportsYahoo Finance · Tue, Sep 8, 2026
- The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AIBeincrypto · Tue, Sep 8, 2026
- Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now247Wallst · Mon, Sep 7, 2026
- Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsightYahoo Finance · Mon, Sep 7, 2026
- Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and ValnevaYahoo Finance · Mon, Sep 7, 2026
- VIRGINIA RETIREMENT SYSTEMS ET Al Invests $79.56 Million in Merck & Co., Inc. $MRKMarketBeat · Mon, Sep 7, 2026
- Merck & Co., Inc. (MRK) Stock Analysis: Navigating a Healthcare Giant with a $370 Billion Market CapDirectorsTalk Interviews · Mon, Sep 7, 2026
- HighTower Advisors LLC Grows Stock Holdings in Merck & Co., Inc. $MRKMarketBeat · Mon, Sep 7, 2026
- Merck & Co., Inc. $MRK Shares Bought by Groupe la FrancaiseMarketBeat · Mon, Sep 7, 2026
- Amundi Has $1.59 Billion Stock Holdings in Merck & Co., Inc. $MRKMarketBeat · Mon, Sep 7, 2026
Congress activity
Disclosed STOCK Act trades in MRK · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Sell | $15K–$50K | 2026-03-27 | 2026-07-21 | |
 Gilbert Cisneros house · CA · traded 2025-12-19 | Buy | $1K–$15K | 2025-12-19 | 2026-01-09 | |
 Julie Johnson house · TX · traded 2025-12-18 | Sell | $1K–$15K | 2025-12-18 | 2026-01-05 | |
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
 Sheri Biggs house · R · SC · traded 2025-03-19 | Sell | $15K–$50K | 2025-03-19 | 2025-10-05 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
Gilbert Cisneros house · D · CA · traded 2025-08-05 | Buy | $1K–$15K | 2025-08-05 | 2025-09-12 | |
 Lisa McClain house · R · MI · traded 2025-08-04 | Sell | $1K–$15K | 2025-08-04 | 2025-09-12 | |
Julie Johnson house · D · TX · traded 2025-08-14 | Sell | $1K–$15K | 2025-08-14 | 2025-09-11 | |
 Marjorie Taylor Greene house · GA · traded 2025-08-28 | Buy | $1K–$15K | 2025-08-28 | 2025-08-29 |
Insider activity
SEC Form 4 transactions in MRK · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Guindo Chirfi EVP, Access, Policy & Comms · Common Stock · 2026-08-13 | Sell | 10K | $1.4M | 2026-08-13 | 2026-08-13 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-12 | Sell | 600 | $79K | 2026-08-12 | 2026-08-12 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-12 | Sell | 11.1K | $1.5M | 2026-08-12 | 2026-08-12 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-11 | Sell | 7.41K | $973K | 2026-08-11 | 2026-08-12 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-11 | Sell | 5.43K | $718K | 2026-08-11 | 2026-08-12 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-10 | Sell | 20.78K | $2.7M | 2026-08-10 | 2026-08-12 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-06 | Sell | 300 | $39K | 2026-08-06 | 2026-08-10 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-06 | Sell | 805 | $105K | 2026-08-06 | 2026-08-10 |
DeLuca Richard R. EVP&Pres, Merck Animal Heallth · Common Stock · 2026-08-06 | Sell | 4.95K | $644K | 2026-08-06 | 2026-08-10 |
Guindo Chirfi EVP, Access, Policy & Comms · Common Stock · 2026-08-06 | Sell | 15K | $2.0M | 2026-08-06 | 2026-08-07 |
SEC filings
EDGAR filings in MRK · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.